Physician profile
Michael D Ries
NPI 1508803362
$7,650,885.58
in general payments reported to CMS, 2019-2025
10 companies · $347K in 2025
The $347K reported for 2025 was more than what 96% of Adult Reconstructive Orthopaedic Surgery providers received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1.3M · 2020: $1.1M · 2021: $1.3M · 2022: $1.2M · 2023: $1.2M · 2024: $1.3M · 2025: $347K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.8M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Consulting Fee: $7,619 · Travel and Lodging: $2,389 · Food and Beverage: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,776,618.73 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,387.50 |
| Consulting Fee | $7,618.75 |
| Travel and Lodging | $2,389.01 |
| Food and Beverage | $649.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $7,408,893.24 | 2019-2025 | Journey II, Real Intelligence, Journey II Xr |
| Encore Medical, Lp | $215,220.78 | 2021 | |
| Stryker Corporation | $15,599.64 | 2025 | Restoration |
| Orthalign INC | $10,689.65 | 2019-2020 | |
| Medacta USA, INC. | $212.42 | 2021 | |
| Avanos Medical | $143.27 | 2019 | |
| Heraeus Medical, LLC. | $76.29 | 2021 | |
| Sanara Medtech INC. | $29.48 | 2022 | |
| Depuy Synthes Sales INC. | $20.81 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.